14Indexed trials
mesh condition
Supranuclear Palsy, Progressive
Intelligence
Supranuclear Palsy, Progressive intelligence: 14 indexed trials, 5 recruiting studies, 13 sponsors across 7 countries.
5Recruiting
13Sponsors
7Countries
Leading sponsors
University of Colorado, Denver20 recruiting
California Pacific Medical Center Research Institute10 recruiting
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico10 recruiting
Fujian Medical University Union Hospital10 recruiting
MD Stem Cells11 recruiting
Molecular NeuroImaging10 recruiting
Oregon Health and Science University11 recruiting
Ospedale Generale Di Zona Moriggia-Pelascini10 recruiting
Queen Mary University of London11 recruiting
Rush University Medical Center10 recruiting
Skane University Hospital11 recruiting
Bastyr University11 recruiting
Geographic activity
United States8trials
Italy2trials
Austria1trials
United Arab Emirates1trials
United Kingdom1trials
Sweden1trials
China1trials
Leading interventions
CUE1 non-invasive device1trials
CUE1+ device active vs sham CUE1+ device1trials
CoMDA associated with Neural Net 91 classificator1trials
DaTscan1trials
Elecsys (Roche) Abeta42, Ttau and Ptau1trials
Flutemetamol F18 Injection1trials
Home Visit Program1trials
Intravenous and Intranasal BMSC1trials
Lumipulse (Fujirebio) Abeta42, Ttau and Ptau1trials
Palliative Care1trials
Physiotherapy1trials
Repetitive transcranial magnetic stimulation (rTMS)1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.